[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100503445":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":18,"locations":28,"responsibleParty":181,"collaborators":183,"id":190,"slug":191,"hasResults":192,"nctId":193,"briefTitle":194,"officialTitle":195,"acronym":196,"eligibilityCriteria":197,"healthyVolunteers":192,"sex":198,"minAge":199,"maxAge":200,"enrollmentInfo":201,"targetDuration":204,"studyType":205,"phases":7,"briefSummary":206,"conditions":207,"keywords":7,"overallStatus":50,"whyStopped":7,"lastUpdateSubmitDate":209,"lastUpdatePostDateStruct":210,"startDateStruct":213,"completionDateStruct":215,"leadSponsor":217,"locationsCount":218},{"fullName":5,"class":6},"Venus MedTech (HangZhou) Inc.","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","transcatheter pulmonary valve implantation (TPVI)","A stent-mounted valve is introduced over a guidewire and positioned in the RVOT, followed by balloon inflation to deploy the valve.",[14],{"name":15,"affiliation":16,"role":17},"Shakeel A. Qureshi, MD","Evelina Children's Hospital","PRINCIPAL_INVESTIGATOR",[19,24],{"name":20,"role":21,"phone":22,"phoneExt":7,"email":23},"Cong Ma","CONTACT","+86 18817939751","macong@venusmedtech.com",{"name":25,"role":21,"phone":26,"phoneExt":7,"email":27},"Ping Zhang","15802168031","zhangping@venusmedtech.com",[29,48,64,79,93,109,123,139,153,169],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"CHU Bordeaux","NOT_YET_RECRUITING","Pessac","New Aquitaine","33600","France","FR",{"type":38,"coordinates":39},"Point",[40,41],-0.6324,44.80565,{"lat":41,"lon":40},[44],{"name":45,"role":21,"phone":46,"phoneExt":7,"email":47},"Jean-Benoît THAMBO","(+33) 05 57 65 62 59","jean-benoit.thambo@chu-bordeaux.fr",{"facility":49,"status":50,"city":51,"state":52,"zip":53,"country":35,"countryCode":36,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Chu Nantes","RECRUITING","Nantes","Pays de la Loire Region","44093",{"type":38,"coordinates":55},[56,57],-1.55336,47.21725,{"lat":57,"lon":56},[60],{"name":61,"role":21,"phone":62,"phoneExt":7,"email":63},"Patrice GUERIN","+33 (0)2 40 16 55 89","patrice.guerin@chu-nantes.fr",{"facility":65,"status":50,"city":66,"state":67,"zip":68,"country":35,"countryCode":36,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Marie Lannelongue","Le Plessis-Robinson","Île-de-France Region","92350",{"type":38,"coordinates":70},[71,72],2.27078,48.78889,{"lat":72,"lon":71},[75],{"name":76,"role":21,"phone":77,"phoneExt":7,"email":78},"Sébastien HASCOËT","+33 6 72 64 10 18","hascoets@gmail.com",{"facility":80,"status":50,"city":81,"state":67,"zip":82,"country":35,"countryCode":36,"cosmosGeoPoint":83,"geoPoint":87,"contacts":88},"Hopital Necker-Enfants malades","Paris","75015",{"type":38,"coordinates":84},[85,86],2.3488,48.85341,{"lat":86,"lon":85},[89],{"name":90,"role":21,"phone":91,"phoneExt":7,"email":92},"MILANI Guiti","0033 1 4494344","guiti.milani@gmail.com",{"facility":94,"status":31,"city":95,"state":96,"zip":97,"country":98,"countryCode":99,"cosmosGeoPoint":100,"geoPoint":104,"contacts":105},"Heart CenterMunich","Munich","Bavaria","81377","Germany","DE",{"type":38,"coordinates":101},[102,103],11.57549,48.13743,{"lat":103,"lon":102},[106],{"name":107,"role":21,"phone":7,"phoneExt":7,"email":108},"Dr. Stanimir Georgiev","georgiev@dhm.mhn.de",{"facility":110,"status":31,"city":111,"state":112,"zip":113,"country":98,"countryCode":99,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Clinic of Congenital Heart Disease","Berlin","State of Berlin","13353",{"type":38,"coordinates":115},[116,117],13.41053,52.52437,{"lat":117,"lon":116},[120],{"name":121,"role":21,"phone":7,"phoneExt":7,"email":122},"Prof. Felix Berger","mailto:felix.berger@dhzc-charite.de",{"facility":124,"status":31,"city":125,"state":126,"zip":127,"country":128,"countryCode":129,"cosmosGeoPoint":130,"geoPoint":134,"contacts":135},"OPBG Rome","Rome","Lazio","165","Italy","IT",{"type":38,"coordinates":131},[132,133],12.51133,41.89193,{"lat":133,"lon":132},[136],{"name":137,"role":21,"phone":7,"phoneExt":7,"email":138},"BUTERA GIANFRANCO","gianfrancobutera@libero.it",{"facility":140,"status":31,"city":141,"state":142,"zip":143,"country":128,"countryCode":129,"cosmosGeoPoint":144,"geoPoint":148,"contacts":149},"S. Donato Milan","Milan","Lombardy","20097",{"type":38,"coordinates":145},[146,147],9.18951,45.46427,{"lat":147,"lon":146},[150],{"name":151,"role":21,"phone":7,"phoneExt":7,"email":152},"Massimo Chessa","massimo.chessa@grupposandonato.it",{"facility":154,"status":31,"city":155,"state":156,"zip":157,"country":158,"countryCode":159,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"Leeds General Infirmary","Leeds","England","LS1 3EX","United Kingdom","UK",{"type":38,"coordinates":161},[162,163],-1.54785,53.79648,{"lat":163,"lon":162},[166],{"name":167,"role":21,"phone":7,"phoneExt":7,"email":168},"Dr. J. Bentham","Jamie.bentham@nhs.net",{"facility":16,"status":31,"city":170,"state":156,"zip":171,"country":158,"countryCode":159,"cosmosGeoPoint":172,"geoPoint":176,"contacts":177},"London","SE1 7EH",{"type":38,"coordinates":173},[174,175],-0.12574,51.50853,{"lat":175,"lon":174},[178],{"name":179,"role":21,"phone":7,"phoneExt":7,"email":180},"Prof. Sir S. Qureshi","mailto:Shakeel.Qureshi@gstt.nhs.uk",{"type":182,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[184,187],{"name":185,"class":186},"IQVIA MedTech BV of Antwerp, Belgium","UNKNOWN",{"name":188,"class":189},"MDCECRO LLC","NETWORK","100503445","observational-study-of-venus-p-valve-100503445",false,"NCT05835349","Observational Study of Venus P-Valve","A Real-World Evidence Observational Study of VenusP-ValveTM System in the Treatment of Patients with Native RVOT Dysfunction","Registry","Inclusion Criteria\n\n1. Patients with native RVOT (including transvalvular patch repair) are present with moderate or greater pulmonary regurgitation with\u002Fwithout stenosis and are clinically indicated for pulmonary valve intervention.\n2. The patient (or the patient's legally authorized representative) is willing to consent to participate in the study and will commit to completing all follow-up requirements.\n\nExclusion Criteria:\n\n1\\. Patients with any condition contraindicated by the IFU or inability to comply with the Venus P-ValveTM System Instructions for Use or the study protocol.","ALL","12 Years","70 Years",{"count":202,"type":203},200,"ESTIMATED","5 Years","OBSERVATIONAL","Real-world evidence, retrospective and prospective, non-randomized, multicenter observational study of VenusP-ValveTM System in treating moderate or greater pulmonary regurgitation with\u002Fwithout pulmonary stenosis in patients with native right ventricular outflow tract (RVOT).",[208],"Right Ventricular Outflow Tract Dysfunction","2025-01-21",{"date":211,"type":212},"2025-01-24","ACTUAL",{"date":214,"type":212},"2024-08-26",{"date":216,"type":203},"2032-12",{"name":5,"class":6},10]